Sullivan, A M <br/><br/>
Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration.  [electronic resource] 

 -  Brain research  Feb 1999 
 - 176-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-8993 
<br/><br/><label>Standard No.: </label>10.1016/s0006-8993(98)01275-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Animals<br/>Bone Morphogenetic Proteins<br/>Dopamine--metabolism<br/>Growth Differentiation Factor 5<br/>Growth Substances--pharmacology<br/>Humans<br/>Injections, Intraventricular<br/>Microinjections<br/>Neuroprotective Agents--pharmacology<br/>Rats<br/>Recombinant Proteins--pharmacology<br/>Rotation<br/>Substantia Nigra--drug effects<br/>Transforming Growth Factor beta--pharmacology<br/>Tyrosine 3-Monooxygenase--analysis